Published Date：Mar.2021
Industry：Chemical & Material
Pages：102 Table Number：126
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Anti Neurofilament L Antibody market in this environment. In terms of revenue, this research report indicated that the global Anti Neurofilament L Antibody market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Anti Neurofilament L Antibody industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Merck aims at producing XX K Units Anti Neurofilament L Antibody in 2020, with XX % production to take place in global market, BioLegend accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Anti Neurofilament L Antibody Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Anti Neurofilament L Antibody Market? Merck BioLegend Cell Signaling Technology Rockland Immunochemicals Bio-Rad Laboratories EnCor Biotechnology ... Major Type of Anti Neurofilament L Antibody Covered in XYZResearch report: Mouse Anti Neurofilament L Antibody Rabbit Anti Neurofilament L Antibody Others Application Segments Covered in XYZResearch Market Academic and Research Institutes Pharma and Biotech Companies Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Anti Neurofilament L Antibody Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Mouse Anti Neurofilament L Antibody -Product Introduction and Major Manufacturers 1.1.2 Rabbit Anti Neurofilament L Antibody -Product Introduction and Major Manufacturers 1.1.3 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Anti Neurofilament L Antibody Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Anti Neurofilament L Antibody Market 3.1.1 Top Companies leading Anti Neurofilament L Antibody Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Anti Neurofilament L Antibody Market 3.2.1 Top Companies leading Anti Neurofilament L Antibody Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Anti Neurofilament L Antibody Market 3.3.1 Top Companies leading Anti Neurofilament L Antibody Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Anti Neurofilament L Antibody Market 3.4.1 Top Companies leading Anti Neurofilament L Antibody Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Anti Neurofilament L Antibody Market 3.5.1 Top Companies leading Anti Neurofilament L Antibody Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Anti Neurofilament L Antibody Market 3.6.1 Top Companies leading Anti Neurofilament L Antibody Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Anti Neurofilament L Antibody Market 3.7.1 Top Companies leading Anti Neurofilament L Antibody Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Anti Neurofilament L Antibody Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Anti Neurofilament L Antibody Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Anti Neurofilament L Antibody Sales and Growth Rate (2021-2027) 5.2 Global Anti Neurofilament L Antibody Sales Value and Growth Rate (2021-2027) 6 Anti Neurofilament L Antibody Competitive Analysis 6.1 Merck 6.1.1 Merck Company Profiles 6.1.2 Merck Product Introduction 6.1.3 Merck Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 BioLegend 6.2.1 BioLegend Company Profiles 6.2.2 BioLegend Product Introduction 6.2.3 BioLegend Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Cell Signaling Technology 6.3.1 Cell Signaling Technology Company Profiles 6.3.2 Cell Signaling Technology Product Introduction 6.3.3 Cell Signaling Technology Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Rockland Immunochemicals 6.4.1 Rockland Immunochemicals Company Profiles 6.4.2 Rockland Immunochemicals Product Introduction 6.4.3 Rockland Immunochemicals Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Bio-Rad Laboratories 6.5.1 Bio-Rad Laboratories Company Profiles 6.5.2 Bio-Rad Laboratories Product Introduction 6.5.3 Bio-Rad Laboratories Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 EnCor Biotechnology 6.6.1 EnCor Biotechnology Company Profiles 6.6.2 EnCor Biotechnology Product Introduction 6.6.3 EnCor Biotechnology Anti Neurofilament L Antibody Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Anti Neurofilament L Antibody Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Anti Neurofilament L Antibody Sales (K Unit) by Type (2026-2027) Figure Global Anti Neurofilament L Antibody Sales (K Unit) and Growth Rate (2026-2027) Figure Global Anti Neurofilament L Antibody Sales Market Share (%) by Type (2019 -2020) Table Global Anti Neurofilament L Antibody Sales Value (Million USD) by Type (2026-2027) Figure Global Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Anti Neurofilament L Antibody Sales Value Market Share (%) by Type (2019-2020) Table Global Anti Neurofilament L Antibody Sales (K Unit) by Application (2026-2027) Table China Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table China Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table China Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure China Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table China Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table China Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table China Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure China Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table EU Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table EU Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table EU Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure EU Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table EU Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table EU Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure EU Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table USA Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table USA Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table USA Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure USA Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table USA Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table USA Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure USA Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table Japan Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table Japan Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table Japan Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table Japan Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table Japan Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure Japan Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table India Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table India Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table India Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure India Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table India Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table India Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table India Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure India Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table Southeast Asia Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table Southeast Asia Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table Southeast Asia Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure Southeast Asia Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Table South America Anti Neurofilament L Antibody Sales (K Unit) of Major Company (2016-2021) Table South America Anti Neurofilament L Antibody Sales Market Share of Major Company (2016-2021) Table South America Anti Neurofilament L Antibody Sales Value (Million USD) of Major Company (2016-2021) Figure South America Anti Neurofilament L Antibody Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Anti Neurofilament L Antibody Sales Value Share of Major Company (2016-2021) Table South America Anti Neurofilament L Antibody Price (USD/Unit), by Type (2019-2020) Table South America Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure South America Anti Neurofilament L Antibody Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Anti Neurofilament L Antibody Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Anti Neurofilament L Antibody Figure Cost Structure of Anti Neurofilament L Antibody in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Anti Neurofilament L Antibody Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Anti Neurofilament L Antibody Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Merck Profiles Table Merck Anti Neurofilament L Antibody Product Introduction Table Merck Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck SWOT Analysis Table BioLegend Profiles Table BioLegend Anti Neurofilament L Antibody Product Introduction Table BioLegend Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure BioLegend SWOT Analysis Table Cell Signaling Technology Profiles Table Cell Signaling Technology Anti Neurofilament L Antibody Product Introduction Table Cell Signaling Technology Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Cell Signaling Technology SWOT Analysis Table Rockland Immunochemicals Profiles Table Rockland Immunochemicals Anti Neurofilament L Antibody Product Introduction Table Rockland Immunochemicals Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Rockland Immunochemicals SWOT Analysis Table Bio-Rad Laboratories Profiles Table Bio-Rad Laboratories Anti Neurofilament L Antibody Product Introduction Table Bio-Rad Laboratories Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Bio-Rad Laboratories SWOT Analysis Table EnCor Biotechnology Profiles Table EnCor Biotechnology Anti Neurofilament L Antibody Product Introduction Table EnCor Biotechnology Anti Neurofilament L Antibody Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
